Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial.

Alexandre Mortier, Jina Khoudary, Sophie van Dooslaer de Ten Ryen, Camille Lannoy, Nicolas Benoit, Nancy Antoine, Sylvie Copine, Hans Van Remoortel, Philippe Vandekerckhove, Veerle Compernolle, Louise Deldicque

Journal: Vox sanguinis 2024;119(2):134-143

PMID: 37997609

Abstract

BACKGROUND AND OBJECTIVES

Most research studies on the effects of repeated plasma donation are observational with different study limitations, resulting in high uncertainty on the link between repeated plasma donation and health consequences. Here, we prospectively investigated the safety of intensive or less intensive plasma donation protocols.

MATERIALS AND METHODS

Sixty-three male subjects participated in this randomized controlled trial and were divided into low-frequency (LF, once/month, n = 16), high-frequency (HF, three times/month, n = 16), very high-frequency (VHF, two times/week, n = 16) and a placebo (P, once/month, n = 15) groups. Biochemical, haematological, clinical, physiological and exercise-related data were collected before (D0), after 1½ months (D42) and after 3 months (D84) of donation.

RESULTS

In VHF, red blood cells, haemoglobin and haematocrit levels decreased while reticulocyte levels increased from D0 to D84. In both HF and VHF, plasma ferritin levels were lower at D42 and D84 compared to D0. In VHF, plasma levels of albumin, immunoglobulin G (IgG), immunoglobulin A (IgA) and immunoglobulin M (IgM) dropped from D0 to D42 and remained lower at D84 than at D0. In HF, plasma IgG, IgA and IgM were lower at D42, and IgG and IgM were lower at D84, compared to D0. Few adverse events were reported in HF and VHF. Repeated plasma donation had no effect on blood pressure, body composition or exercise performance.

CONCLUSION

VHF plasmapheresis may result in a large reduction in ferritin and IgG levels. HF and VHF plasmapheresis may result in little to no difference in other biochemical, haematological, clinical, physiological and exercise-related parameters.

© 2023 The Authors. Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion.

Address: Institute of Neuroscience, UCLouvain, Louvain-la-Neuve, Belgium.; Blood Services, Belgian Red Cross, Mechelen, Belgium.; Centre for Evidence-Based Practice, Belgian Red Cross, Mechelen, Belgium.; Department of Public Health and Primary Care, Leuven Institute for Healthcare Policy, KU Leuven, Leuven, Belgium.; Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Center of Investigation in Clinical Nutrition, UCLouvain, Louvain-la-Neuve, Belgium.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.